Ciclobendazole or cyclobendazole

This classification denotes an antihelminthic agent with the molecular formula C13H13N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JF3KQ40J31, chemically known as 2-benzimidazolecarbamic acid, 5-(cyclopropylcarbonyl)-, methyl ester but generally known as ciclobendazole, which bears US NIH Compound Identifier 35803. European Medicines Agency schedules Ciclobendazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06240MIG. The term CICLOBENDAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). World Health Organization schedules ciclobendazole in its Anatomical Therapeutic Chemical (ATC) Classification. CICLOBENDAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Ciclobendazole or cyclobendazole bears US NLM identifiers UMLS ID C2699486 and NCI Concept Code C78041. SMILES: COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3CC3.